{"title":"Bariatric surgery.","authors":"Hamish Shilton","doi":"10.31128/AJGP-10-24-7432","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In 2023, 15,985 primary bariatric operations were performed in Australia, with sleeve gastrectomy (SG) accounting for 80% of cases. Bariatric surgery offers better long-term weight loss and comorbidity resolution compared with any other treatments, with low morbidity and mortality rates.</p><p><strong>Objective: </strong>This paper evaluates the efficacy, indications, outcomes and long-term considerations of bariatric surgery. It compares the current surgical procedures, SG, Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB), along with alternative weight-loss treatments, focusing on the important aspects for an Australian general practitioner.</p><p><strong>Discussion: </strong>Bariatric surgery remains the most effective treatment for people with obesity, initially achieving 30% total weight loss (TWL) with sustained long-term outcomes. Both SG and RYGB show similar TWL rates at five years (23.7% vs 27.2%). Complication rates are low (1.5-4.8%), and surgery significantly improves or resolves comorbidities, particularly diabetes. Endoscopic and pharmacological treatments are emerging alternatives but lack the long-term efficacy of surgery.</p>","PeriodicalId":54241,"journal":{"name":"Australian Journal of General Practice","volume":"54 4","pages":"202-206"},"PeriodicalIF":1.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Australian Journal of General Practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.31128/AJGP-10-24-7432","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In 2023, 15,985 primary bariatric operations were performed in Australia, with sleeve gastrectomy (SG) accounting for 80% of cases. Bariatric surgery offers better long-term weight loss and comorbidity resolution compared with any other treatments, with low morbidity and mortality rates.
Objective: This paper evaluates the efficacy, indications, outcomes and long-term considerations of bariatric surgery. It compares the current surgical procedures, SG, Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB), along with alternative weight-loss treatments, focusing on the important aspects for an Australian general practitioner.
Discussion: Bariatric surgery remains the most effective treatment for people with obesity, initially achieving 30% total weight loss (TWL) with sustained long-term outcomes. Both SG and RYGB show similar TWL rates at five years (23.7% vs 27.2%). Complication rates are low (1.5-4.8%), and surgery significantly improves or resolves comorbidities, particularly diabetes. Endoscopic and pharmacological treatments are emerging alternatives but lack the long-term efficacy of surgery.
期刊介绍:
The Australian Journal of General Practice (AJGP) aims to provide relevant, evidence-based, clearly articulated information to Australian general practitioners (GPs) to assist them in providing the highest quality patient care, applicable to the varied geographic and social contexts in which GPs work and to all GP roles as clinician, researcher, educator, practice team member and opinion leader. All articles are subject to peer review before they are accepted for publication.